![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_02.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
![Table 3 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar Table 3 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/30a807d21caddb62b9e22272bed34f1929918dcc/7-Table2-1.png)
Table 3 from Optimal use of β-blockers in high-risk hypertension: A guide to dosing equivalence | Semantic Scholar
![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_03.gif)
Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio
![The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues: A Report From the American College of Cardiology | Journal of the American College of Cardiology The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues: A Report From the American College of Cardiology | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/9d0b3b70-7794-499b-89bc-e504f8f0c94e/gr15.jpg)
The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues: A Report From the American College of Cardiology | Journal of the American College of Cardiology
![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers](https://ijp-online.com/articles/2014/46/5/images/Indian%20J%20Pharmacol_2014_46_5_485_140577_t2.jpg)
Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
![Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d74cb01d7491e0648e608b1b314629930ea1a050/3-Table1-1.png)
Table 1 from Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial. | Semantic Scholar
![Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers](https://ijp-online.com/articles/2014/46/5/images/Indian%20J%20Pharmacol_2014_46_5_485_140577_t4.jpg)